COVID-19 Secondary Uses Oversight and Scrutiny Group

Providing oversight of secondary uses of data from the GM Care Record

The purpose of the GM COVID-19 Secondary Uses Oversight and Scrutiny Group is to provide transparency to data controllers, the public and wider health and care system stakeholders about how data contained within the GM Care Record is used to support service planning, analytics, population health management and research.

The group meets every two weeks to consider whether or not proposed uses for the data are appropriate, benefit patients and services, are COVID-19 related and fall within the agreed parameters.

It is chaired by Dr Kiran Patel, GP and Medical Director at the Bury GP Federation.

A summary of the key decisions made by the group are listed below:

Decision Log

Item no.TitleDescriptionDate presented to GroupGroup decision
1

COVID-19 DPIA for university research

Review of the DPIA for university research

27 July 2020

Endorsed Approach

2

Data Access Process

Review of the data access process to support secondary uses and research

27 July 2020

Endorsed Approach

3

Governance Arrangements

Summary of the governance arrangements to support secondary uses and research

7 September 2020

Endorsed Approach

4

Terms of Reference​

Review of final Terms of Reference

05 October 2020

Endorsed approach

5

Decision Log​

The group supported the decision log but requested more details to be added about why decisions were made and when items were not supported as well as approved.

05 October 2020

Endorsed approach

6

Use case applications

The group confirmed they would prefer to receive full copies of use case applications for information.

05 October 2020

Endorsed approach

7

Public Members

The group requested that public members on the research governance group and the oversight & scrutiny committee were joined up, and that the public should have the opportunity to input into potential studies (eg, impact of COVID on BAME communities)

05 October 2020

Endorsed approach

8

GM Mortality Planning Group/Primary Care Cell

Data required for mortuary capacity planning.

02 December 2020

Decision Endorsed

Back to top